Lab901 and Biofortuna to collaborate on automated PCR Dx for HLA and Coeliac disease

17-Nov-2009 - United Kingdom

Lab901 and Biofortuna announced that they will collaborate on the launch of an automated PCR Dx system for the rapid detection of certain HLA-related diseases such as coeliac disease. Lab901 will be optimising its automated ScreenTape® PCR diagnostics platform for use with Biofortuna’s range of multiplex PCR diagnostics kits for the detection of Coeliac disease, and other HLA related disease such as reactive arthritis, diabetes and drug hypersensitivity.

Dr Mike Bunce, Biofortuna’s CEO said “We are very excited about the launch of our first line of kits for Coeliac disease susceptibility and Abacavir hypersensitivity. Biofortuna’s blend of easy-to-use one-step PCR technology and multiplexing capability means we are confident of quickly taking market share. Having evaluated several automated systems, we have chosen to work with Lab901 because of the ease-of-use, cost-effectiveness and reproducibility of the ScreenTape platform".

Financial terms were not disclosed.

Other news from the department business & finance

Most read news

More news from our other portals

See the theme worlds for related content

Last viewed contents

Thermo Fisher Scientific Announces Collaborative Partnership with Vascular Proteomics Group at King's College London

Gilson announces the opening of the Gilson Service Center of Excellence

The longer spilled oil lingers in freshwater, the more persistent compounds it produces - Weathering assessments of polar and non-polar petroleum components using Orbitrap and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

The longer spilled oil lingers in freshwater, the more persistent compounds it produces - Weathering assessments of polar and non-polar petroleum components using Orbitrap and Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.

First of 100 Arab Human Genomes Sequenced by Saudi Biosciences, Beijing Genomics Institute Shenzhen, and CLC bio

QIAGEN and Procognia Enter into a Marketing and Licensing Agreement Targeting the Field of Protein Glycoanalysis

Bio Nano Consulting chosen by a Top 5 pharma company to provide specialist nanotech product development services

Eurofins expands presence in Discovery Pharmacology with the acquisition of Pan Labs US

Discovery of a new gene critical in the development of lung and pancreatic cancers - Inhibition of this gene provokes a drastic reduction in the size of these tumors

Discovery of a new gene critical in the development of lung and pancreatic cancers - Inhibition of this gene provokes a drastic reduction in the size of these tumors

PerkinElmer completes sale of medical imaging business to Varex Imaging

Proteros and University of Cincinnati, Drug Discovery Center establish collaboration to offer high-throughput screening services

Agilent Technologies and National University of Singapore Sign Research Collaboration Agreement for Lipidomics Research

Mystery of Novel Clove-Like Off-Flavor in Orange Juice Solved - Tracking down off-flavours using techniques such as gas chromatography-olfactometry and aroma extract dilution analysis

Mystery of Novel Clove-Like Off-Flavor in Orange Juice Solved - Tracking down off-flavours using techniques such as gas chromatography-olfactometry and aroma extract dilution analysis